506365 — Chemo Pharma Laboratories Cashflow Statement
0.000.00%
- IN₹200.93m
- IN₹133.39m
- 38
- 22
- 89
- 49
Annual cashflow statement for Chemo Pharma Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | |
---|---|---|
Period Length: | 12 M | 12 M |
Source: | ARS | ARS |
Standards: | IAS | IAS |
Status: | Final | Final |
Net Income/Starting Line | 0.732 | 16.4 |
Depreciation | ||
Non-Cash Items | -7.11 | -8.48 |
Other Non-Cash Items | ||
Changes in Working Capital | -0.591 | -0.806 |
Change in Other Assets | ||
Change in Other Liabilities | ||
Other Operating Cash Flow | ||
Cash from Operating Activities | -6.83 | 7.24 |
Other Investing Cash Flow Items | 6.3 | -5.25 |
Change in Net Investments | ||
Purchase of Investments | ||
Other Investing Cash Flow | ||
Cash from Investing Activities | 6.3 | -5.25 |
Financing Cash Flow Items | -0.763 | -1.49 |
Other Financing Cash Flow | ||
Cash from Financing Activities | -0.763 | -1.49 |
Beginning Cash Balance | ||
Ending Cash Balance | ||
Net Change in Cash | -1.3 | 0.499 |